Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Post by trapmasteron Nov 30, 2016 10:21pm

120 Views

Post# 25537932

Reverse Spit

Reverse split only is good for the CEO and his buddy, it gets rid of us nobodies, I voted against it and I voted to get rid of the present CEO, nothing but a scam, got a call from someone in there department to buy early on, they likely don't even have any say on the clone property, all B.S,

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload